Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Filings indexed 1,611 across all filing types
Latest filing 2023-03-10 Fund Information / Fact…
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
112年2月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief financial summary report showing monthly and cumulative net operating revenue figures for a company named 杏輝 for the period 民國112年02月 (February 2023). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document length is only 767 characters, which is very short and contains no detailed financial statements or analysis. It appears to be a brief factsheet or summary of key financial data rather than a full report or announcement. Therefore, the best fitting category is Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2023-03-10 Chinese
112年02月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, chairpersons, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial statements, earnings data, or report announcements. The document is not a full annual or interim report, nor a call transcript or presentation. It is a report of insider share transactions and holdings, which matches the definition of Director's Dealing filings.
2023-03-07 Chinese
112年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on insider shareholdings and related pledges, which is characteristic of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document length is 3467 characters, which is relatively short but contains substantive insider shareholding data rather than just an announcement. Therefore, it fits best under the category of Director's Dealing (DIRS).
2023-03-07 Chinese
112年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (杏輝) providing information about guarantees and endorsements, including amounts and limits, for the current and previous months. It is a regulatory disclosure related to financial guarantees and endorsements rather than a full financial report or announcement of a meeting or voting results. The document is short (624 characters) and contains specific financial data about guarantees, which is typical of a regulatory filing. There is no indication that this is an annual or interim report, audit report, or any other specific report type. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2023-02-10 Chinese
112年1月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summarized revenue report for a company named 杏輝 for the month and year-to-date of 民國112年01月 (January 2023). It contains numerical financial data such as net operating revenue for the current month and year compared to the previous year, with percentage changes and notes on accounting standards (IFRS). The document is short (770 characters) and appears to be a periodic financial summary rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more consistent with a brief financial update or summary. Given the nature and length, it fits best under the category of Interim / Quarterly Report (IR), as it provides substantive financial data for a period shorter than a full fiscal year.
2023-02-10 Chinese
112年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, chairpersons, general managers, and their family members. It lists the number of shares held, changes in holdings, and other related information. This type of document is typical of disclosures related to insider share transactions or holdings by directors and executives. There is no indication of financial statements, earnings data, or management discussion. The document is not a report or announcement of a report but a direct disclosure of insider shareholdings. Therefore, it fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2023-02-03 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.